We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
HTG Molecular Diagnostics Inc | NASDAQ:HTGM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.48 | 0.485 | 0.4997 | 0 | 01:00:00 |
HTG Molecular Diagnostics, Inc.
|
(Name of Issuer)
|
Common Stock, $0.001 par value
|
(Title of Class of Securities)
|
40434H 104
|
(CUSIP Number)
|
November 17, 2016
|
(Date of Event which Requires Filing of this Statement)
|
CUSIP No.
|
40434H 104
|
1
|
Names of Reporting Person:
|
||
QIAGEN N.V.
|
|||
2
|
Check the appropriate box if a member of a Group (see instructions)
|
||
(a) [x]
(b) [ ] |
|||
3
|
SEC Use Only
|
||
|
|||
4
|
Citizenship or Place of Organization
|
||
The Netherlands
|
|||
Number of Shares Beneficially Owned by Each Reporting Person With:
|
5
|
Sole Voting Power
|
|
833,333
|
|||
6
|
Shared Voting Power
|
||
|
|||
7
|
Sole Dispositive Power
|
||
833,333
|
|||
8
|
Shared Dispositive Power
|
||
|
|||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
||
833,333
|
|||
10
|
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
|
||
[ ]
|
|||
11
|
Percent of class represented by amount in row (9)
|
||
10.6%
|
|||
12
|
Type of Reporting Person (See Instructions)
|
||
FI
|
CUSIP No.
|
40434H 104
|
1
|
Names of Reporting Person:
|
||
QIAGEN North American Holdings, Inc.
|
|||
2
|
Check the appropriate box if a member of a Group (see instructions)
|
||
(a) [x]
(b) [ ] |
|||
3
|
SEC Use Only
|
||
|
|||
4
|
Citizenship or Place of Organization
|
||
California
|
|||
Number of Shares Beneficially Owned by Each Reporting Person With:
|
5
|
Sole Voting Power
|
|
0
(1)
|
|||
6
|
Shared Voting Power
|
||
|
|||
7
|
Sole Dispositive Power
|
||
0
(1)
|
|||
8
|
Shared Dispositive Power
|
||
|
|||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
||
0
(1)
|
|||
10
|
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
|
||
[ ]
|
|||
11
|
Percent of class represented by amount in row (9)
|
||
|
|||
12
|
Type of Reporting Person (See Instructions)
|
||
CO
|
|||
(1)
The 833,333 shares of Common Stock of the Issuer are held of record by QIAGEN North American Holdings, Inc., a wholly-owned subsidiary of QIAGEN N.V.
|
(a)
|
Name of Person Filing:
QIAGEN N.V.
|
(b)
|
Address of Principal Business Office or, if None, Residence:
Hulsterweg 82, 5912 PL Venlo, The Netherlands
|
(c)
|
Citizenship:
The Netherlands
|
(d)
|
Title and Class of Securities:
Common Stock, par value $0.001 per share.
|
(e)
|
CUSIP No.:
40434H 104
|
Item 3.
|
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
(a)
|
Amount Beneficially Owned:
833,333
|
(iii)
|
Sole power to dispose or to direct the disposition of:
833,333
|
(iv)
|
Shared power to dispose or to direct the disposition of:
|
Item 6.
|
Ownership of more than Five Percent on Behalf of Another Person.
|
Item 7.
|
Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person.
|
Item 8.
|
Identification and classification of members of the group.
|
Item 9.
|
Notice of Dissolution of Group.
|
Item 10.
|
Certifications.
|
Dated: November 22, 2016
|
|
|
|
QIAGEN N.V.
|
|
|
QIAGEN North American Holdings, Inc.
|
|
|
|
|
By:
|
/s/ Roland Sackers
|
|
|
Roland Sackers
|
|
|
Chief Financial Officer
|
1 Year HTG Molecular Diagnostics Chart |
1 Month HTG Molecular Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions